← Evidence map

TrialHuman vaccines & immunotherapeutics2022

Long-Term immunopersistence and safety of the

Xingmei Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35417301